Skip to main content
. 2022 Sep 8;122(2):121–131. doi: 10.1016/j.jfma.2022.09.004

Figure 2.

Fig. 2

Anti SARS-CoV-2 spike IgG antibody responses (BAU/mL) in the study subjects. (A) Antibody responses in the study subjects from the three groups at the day before and 28 days after vaccination with the third dose of the mRNA vaccine. (B) Comparison of the antibody responses between individuals following a three- and two-dose vaccination schedule. ChAdOx1/mRNA-1273 indicates a heterologous mRNA-1273 vaccine boost after priming with the adenoviral vectored ChAdOx1 vaccine. The number in parenthesis indicates the interval (weeks) between the first and second doses of the respective vaccines. mRNA-1273/mRNA-1273 indicates a homologous mRNA-1273 vaccine regimen. Mann–Whitney U test was performed to compare the antibody responses between the groups. P values have been indicated when a statistical significance was determined. Abbreviations: ELISA S-IgG.